Skip to content
Universidad del Mar SIBUMAR Descubridor Institucional UMAR
  • Inicio
  • Búsqueda avanzada
  • Explorar
  • Login
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
Advanced
  • Real‐world analysis of CPX ‐351 in AML ‐ MR : A multicentre study from the MARROW consortium
Cover Image

Real‐world analysis of CPX ‐351 in AML ‐ MR : A multicentre study from the MARROW consortium

Fuente: Wiley Open Access
Saved in:
Bibliographic Details
Main Authors: Daniel T. Peters, Deedra Nicolet, Yazan F. Madanat, Jesus Gonzalez‐Lugo, Alex Ambinder, Onyee Chan, Charles E. Foucar, Kieran D. Sahasrabudhe, Justice Ameyi, Krzysztof Mrózek, Tara Lin, Najla Al‐Ali, Jeffery Lancet, Bianca Barredo, Lauren G. Banaszak, Michael J. Hochman, Brittany K. Ragon, Christine M. McMahon, Tamanna Haque, Alice S. Mims, Ann‐Kathrin Eisfeld, Joshua F. Zeidner
Format: Artículo Open Access
Published: Wiley 2025
Subjects:
British Journal of Haematology
Online Access:
Acceder al recurso
Tags: Add Tag
No Tags, Be the first to tag this record!
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Save to List
  • Permanent link
  • Holdings
  • Description
  • Comments
  • Similar Items
  • Staff View

Internet

https://onlinelibrary.wiley.com/doi/10.1111/bjh.70274

Similar Items

  • CREST‐UK: Real‐world effectiveness, safety and outpatient delivery of CPX‐351 for first‐line treatment of newly diagnosed therapy‐related AML and AML with myelodysplasia‐related changes in the UK
    by: Priyanka Mehta, et al.
    Published: (2024)
  • CPX‐351 +/− gemtuzumab ozogamicin as induction therapy for adult patients with newly diagnosed, favourable‐intermediate risk, FLT3‐ITD negative, AML: A pilot study
    by: Chezi Ganzel, et al.
    Published: (2024)
  • Case of CPX ‐351‐Induced Purpuric Rash Occurred in a Patient With Pure Erythroid Leukemia
    by: Nobuyuki Asano, et al.
    Published: (2025)
  • Real World Study on the Best CPX ‐351 Treatment Duration and Timing for Allogeneic Stem Cell Transplantation
    by: Fabio Guolo, et al.
    Published: (2025)
  • A Phase 2 Trial of CPX‐351 Combined With Venetoclax in Relapsed or Refractory Acute Myeloid Leukemia
    by: Tapan M. Kadia, et al.
    Published: (2025)
Universidad del Mar
Universidad del MarSistema Bibliotecario de la Universidad del MarDescubridor Institucional UMARImplementación y desarrollo: Mtro. Carlos Alonso Albores Pérez
InicioBúsqueda avanzadaExplorar
Visitas al Descubridor: 387,319© 2026 Universidad del Mar